NG2 anticorps (AA 2247-2308)
-
- Antigène Voir toutes NG2 (MCSP) Anticorps
- NG2 (MCSP) (Melanoma Associated Chondroitin Sulfate Proteoglycan (MCSP))
-
Épitope
- AA 2247-2308
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp NG2 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Flow Cytometry (FACS)
- Purification
- Purified antibody
- Immunogène
- Purified recombinant fragment of human CSPG4 (AA: 2247-2308) expressed in E. coli.
- Isotype
- IgG1
- Top Product
- Discover our top product MCSP Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1.0 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 0.5 % protein stabilizer.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
-
- Antigène
- NG2 (MCSP) (Melanoma Associated Chondroitin Sulfate Proteoglycan (MCSP))
- Autre désignation
- CSPG4 (MCSP Produits)
- Synonymes
- anticorps HMW-MAA, anticorps MCSP, anticorps MCSPG, anticorps MEL-CSPG, anticorps MSK16, anticorps NG2, anticorps 4732461B14Rik, anticorps AN2, anticorps Ng2, anticorps HSMCSGEN1, anticorps MCS, anticorps chondroitin sulfate proteoglycan 4, anticorps sperm mitochondria associated cysteine rich protein, anticorps CSPG4, anticorps Cspg4, anticorps SMCP
- Sujet
- A human melanoma-associated chondroitin sulfate proteoglycan plays a role in stabilizing cell-substratum interactions during early events of melanoma cell spreading on endothelial basement membranes.CSPG4 represents an integral membrane chondroitin sulfate proteoglycan expressed by human malignant melanoma cells.
- Poids moléculaire
- 250.0 kDa
- ID gène
- 1464
- UniProt
- Q6UVK1
- Pathways
- Glycosaminoglycan Metabolic Process
-